{"id":"https://openalex.org/W2181539675","doi":null,"title":"Pharmacologic Treatment of Equine Self-Mutilation Syndrome","display_name":"Pharmacologic Treatment of Equine Self-Mutilation Syndrome","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2181539675","mag":"2181539675"},"language":"en","primary_location":{"id":"mag:2181539675","doi":null,"is_oa":false,"landing_page_url":"http://www.jarvm.com/articles/Vol2Iss2/DODMANJARVMVol2No2.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2181539675"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007922621","display_name":"Nicholas H. Dodman","orcid":"https://orcid.org/0000-0001-9742-3656","observed_orcids":["https://orcid.org/0000-0001-9742-3656"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicholas H. Dodman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061168719","display_name":"Louis Shuster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Louis Shuster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028076148","display_name":"Gary J. Patronek","orcid":"https://orcid.org/0009-0004-1205-1363","observed_orcids":["https://orcid.org/0009-0004-1205-1363"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gary J. Patronek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110280243","display_name":"Linda Kinney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linda Kinney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":6,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10872","display_name":"Veterinary Equine Medical Research","score":0.9340999722480774,"subfield":{"id":"https://openalex.org/subfields/3402","display_name":"Equine"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10872","display_name":"Veterinary Equine Medical Research","score":0.9340999722480774,"subfield":{"id":"https://openalex.org/subfields/3402","display_name":"Equine"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11905","display_name":"Veterinary Pharmacology and Anesthesia","score":0.05590000003576279,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/horses","display_name":"horses","score":0.8069999814033508},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.675000011920929},{"id":"https://openalex.org/keywords/acepromazine","display_name":"acepromazine","score":0.9049999713897705},{"id":"https://openalex.org/keywords/detomidine","display_name":"detomidine","score":0.8989999890327454},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonists","display_name":"dopamine antagonists","score":0.6909999847412109},{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-antagonists","display_name":"alpha2-adrenoceptor antagonists","score":0.9089999794960022},{"id":"https://openalex.org/keywords/hemiballism","display_name":"hemiballismus","score":0.8539999723434448},{"id":"https://openalex.org/keywords/neurotransmitter-systems","display_name":"neurotransmitter systems","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6473759412765503},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.631784200668335},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.6053546071052551},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.5604732632637024},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5096967220306396},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47676974534988403},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4746059775352478},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4342937767505646},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4104629456996918},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38456565141677856},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3645413815975189},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.16132089495658875},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07435065507888794}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2181539675","doi":null,"is_oa":false,"landing_page_url":"http://www.jarvm.com/articles/Vol2Iss2/DODMANJARVMVol2No2.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W9702828","https://openalex.org/W37811855","https://openalex.org/W71116213","https://openalex.org/W120978159","https://openalex.org/W1486802146","https://openalex.org/W1552682390","https://openalex.org/W1601208936","https://openalex.org/W1978453350","https://openalex.org/W1982147144","https://openalex.org/W1983337012","https://openalex.org/W1991043200","https://openalex.org/W1991431081","https://openalex.org/W1998618539","https://openalex.org/W2002509497","https://openalex.org/W2003796075","https://openalex.org/W2011629057","https://openalex.org/W2040716453","https://openalex.org/W2048812136","https://openalex.org/W2050390911","https://openalex.org/W2064118350","https://openalex.org/W2066486403","https://openalex.org/W2090003581","https://openalex.org/W2109789351","https://openalex.org/W2142890840","https://openalex.org/W2312315657","https://openalex.org/W2468743251","https://openalex.org/W2469189912","https://openalex.org/W2470093863"],"related_works":["https://openalex.org/W37811855","https://openalex.org/W2461564747","https://openalex.org/W2164769847","https://openalex.org/W2398110941","https://openalex.org/W2408771337","https://openalex.org/W2745622553","https://openalex.org/W1011749757","https://openalex.org/W2395050523","https://openalex.org/W1993598901","https://openalex.org/W2784603519"],"abstract_inverted_index":{"The":[0],"effects":[1],"of":[2,23,48,82,92,99,128],"drugs":[3,49],"that":[4],"either":[5],"stimulate":[6],"or":[7,84],"inhibit":[8],"central":[9],"opioid,":[10],"dopamine,":[11],"norepinephrine,":[12],"and":[13,131],"serotonin":[14],"neurotransmitter":[15,57],"systems":[16,58],"were":[17,41,59,75,95,109],"examined":[18],"in":[19,34,64,123,146],"horses":[20,38,63],"demonstrating":[21],"signs":[22],"equine":[24],"self-mutilation":[25],"syndrome":[26,33,74],"(ESMS),":[27],"a":[28,65,100,116,120,140],"condition":[29],"similar":[30],"to":[31,61,105],"Tourette\u2019s":[32],"humans.":[35],"Eight":[36],"flankbiting":[37],"with":[39,72,97],"ESMS":[40,126],"recruited":[42],"for":[43,51,77],"the":[44,55,62,73,93,113,124,151],"study.":[45,68],"A":[46],"series":[47],"selected":[50],"their":[52],"activity":[53],"on":[54],"aforementioned":[56],"administered":[60],"saline-controlled":[66],"behavioral":[67],"Specific":[69],"behaviors":[70,127],"associated":[71],"videotaped":[76],"4":[78],"hours":[79],"following":[80],"administration":[81],"drug":[83],"saline.":[85],"Behaviors":[86],"recorded":[87],"hourly":[88],"during":[89],"each":[90],"phase":[91],"study":[94],"compared":[96],"those":[98],"composite":[101],"saline":[102],"control":[103],"baseline":[104],"determine":[106],"whether":[107],"there":[108],"significant":[110,121,141],"differences":[111],"among":[112],"treatments.":[114],"Acepromazine,":[115],"dopamine":[117],"blocker,":[118],"produced":[119,139],"reduction":[122,145],"primary":[125],"self-mutilative":[129],"attempts":[130],"hemiballismus.":[132],"Detomidine,":[133],"an":[134],"\u03b1":[135],"-2":[136],"antagonist,":[137],"also":[138],"(P":[142],"<":[143],".05)":[144],"these":[147],"behaviors,":[148],"as":[149],"did":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2181539675","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
